TY  - GEN
AU  - van Poelgeest,Mariette I E
AU  - Welters,Marij J P
AU  - van Esch,Edith M G
AU  - Stynenbosch,Linda F M
AU  - Kerpershoek,Gijs
AU  - van Persijn van Meerten,Els L
AU  - van den Hende,Muriel
AU  - Löwik,Margriet J G
AU  - Berends-van der Meer,Dorien M A
AU  - Fathers,Lorraine M
AU  - Valentijn,A Rob P M
AU  - Oostendorp,Jaap
AU  - Fleuren,Gert Jan
AU  - Melief,Cornelis J M
AU  - Kenter,Gemma G
AU  - van der Burg,Sjoerd H
TI  - HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
SN  - 1479-5876
PY  - 2013///1231
KW  - Adult
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Cell Proliferation
KW  - Cytokines
KW  - immunology
KW  - Female
KW  - Genital Neoplasms, Female
KW  - therapy
KW  - Human papillomavirus 16
KW  - Humans
KW  - Immunotherapy
KW  - methods
KW  - Middle Aged
KW  - Oncogene Proteins, Viral
KW  - Papillomavirus E7 Proteins
KW  - Papillomavirus Vaccines
KW  - Recurrence
KW  - Regression Analysis
KW  - Repressor Proteins
KW  - Uterine Cervical Neoplasms
KW  - Vaccines, Subunit
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1479-5876-11-88
ER  -